Evidence from the Portuguese PREVADIAB2 study

Funding Information: The authors thank the study participants for commitment and loyalty. The authors would like to acknowledge the guidance of the late PD Dr. Bernhard B. Singer, PhD and from Verena Schmitt, PhD from the Universit\u00E4tsklinikum, Essen, Germany for their guidance on setting up the ELISA analysis of circulating CEACAM1 levels. This study was supported by \u201CFunda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia\u201D \u2013 iNOVA4Health (UIDB/Multi/04462/2020), by the European Commission, Horizon Europe Framework Programme, PAS GRAS (Grant agreement n. 101080329) and by the Sociedade Portuguesa de Diabetologia. The study was also partly supported by grants from the US National Institutes of Health [R01-DK054254 and R01-MD012579] and from the Osteopathic Heritage Foundation J.J. Kopchick, PhD, Endowed Eminent Research Chair to SMN. Funding Information: The authors thank the study participants for commitment and loyalty. The authors would like to acknowledge the guidance of the late PD Dr. Bernhard B. Singer, PhD and from Verena Schmitt, PhD from the Universit\u00E4tsklinikum, Essen, Germany for their guidance on setting up the ELISA analysis of circulating CEACAM1 levels. This study was supported by \u201CFunda\u00E7\u00E3o para a Ci\u00EAncia e a Tecnologia\u201D \u2013 iNOVA4Health (UIDB/Multi/04462/2020), by the European Commission, Horizon Europe Framework Programme, PAS GRAS (Grant agreement n. 101080329) and by the Sociedade Portuguesa de Diabetologia. The study was also partly supported by grants from the US National Institutes of Health [R01\u2010DK054254 and R01\u2010MD012579] and from the Osteopathic Heritage Foundation J.J. Kopchick, PhD, Endowed Eminent Research Chair to SMN. Publisher Copyright: © 2024 The Author(s). European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.